Last reviewed · How we verify
EDETATE DISODIUM
EDETATE DISODIUM is a drug. It is currently FDA-approved (first approved 1982).
Edetate disodium is a chelating agent that targets calcium. It is being studied in various clinical trials for conditions such as Kaposi Sarcoma, HIV Infections, and Brain and Central Nervous System Tumors.
At a glance
| Generic name | EDETATE DISODIUM |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1982 |
Approved indications
Common side effects
Key clinical trials
- Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones (PHASE1)
- Repurposing Tilmanocept for Cardiac Sarcoidosis (PHASE2)
- To Compare Post-Extraction Use of a Novel Ethylenediaminetetraacetic Acid (EDTA) Post-operative Mouth Rinse and Daily Use EDTA Mouth Rinse and Standard 0.12% Chlorhexidine (CHX) Post-operative Mouth Rinse and Daily Use Essential Oil (EO) Mouth Rinse. (NA)
- Effect of Novel Exhalational Delivery System With Fluticasone (EDS-FLU) on Eustachian Tube Dysfunction (ETD) (PHASE2)
- Validation of Respiratory Epithelial Functional Assessment to Predict Clinical Efficacy of Orkambi®. (NA)
- Skin Barrier Function and Inflammation in Aging: The BIA Study (PHASE4)
- Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
- Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EDETATE DISODIUM CI brief — competitive landscape report
- EDETATE DISODIUM updates RSS · CI watch RSS
Frequently asked questions about EDETATE DISODIUM
What is EDETATE DISODIUM?
EDETATE DISODIUM is a Small molecule drug.
When was EDETATE DISODIUM approved?
EDETATE DISODIUM was first approved on 1982.
What development phase is EDETATE DISODIUM in?
EDETATE DISODIUM is FDA-approved (marketed).
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing